Literature DB >> 7473711

Myotube-specific activity of the human aldolase A M-promoter requires an overlapping binding site for NF1 and MEF2 factors in addition to a binding site (M1) for unknown proteins.

M Salminen1, F Spitz, M Y Fiszman, J Demignon, A Kahn, D Daegelen, P Maire.   

Abstract

The human aldolase A gene is expressed in several tissues through the use of three alternative promoters. The activity of one of the promoters, pM, is restricted to skeletal muscle. We reported previously that a proximal 280 bp pM fragment confers tissue-specific expression to a CAT reporter gene in transgenic mice. This small regulatory region directs expression to muscle composed mainly of fast-twitch fibers. Here we show that a minimal promoter fragment from base-pairs -164 to +45 is sufficient to highly active pM during myoblast differentiation in cell culture and demonstrate that two DNA elements play a major role in this activation. These elements consist of a binding site (M1) for unknown ubiquitous proteins and an overlapping binding site for MEF2 and NF1 families of transcription factors. The NF1 factor constitute the main binding activity on the MEF2/NF1 site and, interestingly, some of the DNA-protein complexes that form with muscle nuclear extracts on the NF1 element differ from those that form with non-muscular extracts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473711     DOI: 10.1006/jmbi.1995.0532

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype.

Authors:  Raphaelle Grifone; Christine Laclef; François Spitz; Soledad Lopez; Josiane Demignon; Jacques-Emmanuel Guidotti; Kiyoshi Kawakami; Pin-Xian Xu; Robert Kelly; Basil J Petrof; Dominique Daegelen; Jean-Paul Concordet; Pascal Maire
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  A combination of MEF3 and NFI proteins activates transcription in a subset of fast-twitch muscles.

Authors:  F Spitz; M Salminen; J Demignon; A Kahn; D Daegelen; P Maire
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

3.  Independence and interdependence of the three human aldolase A promoters in transgenic mice.

Authors:  C Moch; A Kahn; D Daegelen
Journal:  Gene Expr       Date:  1996

4.  DNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFI.

Authors:  P Tarapore; C Richmond; G Zheng; S B Cohen; B Kelder; J Kopchick; U Kruse; A E Sippel; C Colmenares; E Stavnezer
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

5.  Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site.

Authors:  F Spitz; J Demignon; A Porteu; A Kahn; J P Concordet; D Daegelen; P Maire
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

6.  Fast-muscle-specific DNA-protein interactions occurring in vivo at the human aldolase A M promoter are necessary for correct promoter activity in transgenic mice.

Authors:  M Salminen; S López; P Maire; A Kahn; D Daegelen
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

7.  Fiber-type-specific transcription of the troponin I slow gene is regulated by multiple elements.

Authors:  S Calvo; P Venepally; J Cheng; A Buonanno
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

8.  The CAAT-binding transcription factor 1/nuclear factor 1 binding site is important in beta-myosin heavy chain antisense promoter regulation in rats.

Authors:  Julia M Giger; Paul W Bodell; Kenneth M Baldwin; Fadia Haddad
Journal:  Exp Physiol       Date:  2009-08-14       Impact factor: 2.969

9.  MyoD reprogramming requires Six1 and Six4 homeoproteins: genome-wide cis-regulatory module analysis.

Authors:  Marc Santolini; Iori Sakakibara; Morgane Gauthier; Francesc Ribas-Aulinas; Hirotaka Takahashi; Tatsuya Sawasaki; Vincent Mouly; Jean-Paul Concordet; Pierre-Antoine Defossez; Vincent Hakim; Pascal Maire
Journal:  Nucleic Acids Res       Date:  2016-06-14       Impact factor: 16.971

10.  A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy.

Authors:  Johanna Pruller; Isabella Hofer; Massimo Ganassi; Philipp Heher; Michelle T Ma; Peter S Zammit
Journal:  Cancer Gene Ther       Date:  2020-09-25       Impact factor: 5.987

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.